OpenURL Connection Search

Select item for more details and to access through your institution.

Camelid‐derived Tcell engagers harnessing human γδ T cells as promising antitumor immunotherapeutic agents.
Published in:
European Journal of Immunology, 2024, v. 54, n. 8, p. 1, doi. 10.1002/eji.202350773
By:
- Boutin, Lola;
- Barjon, Clément;
- Chauvet, Morgane;
- Lafrance, Laura;
- Senechal, Eric;
- Bourges, Dorothée;
- Vigne, Emmanuelle;
- Scotet, Emmanuel
Publication type:
Article
Towards Deciphering the Hidden Mechanisms That Contribute to the Antigenic Activation Process of Human Vγ9Vδ2 T Cells.
Published in:
Frontiers in Immunology, 2018, p. 1, doi. 10.3389/fimmu.2018.00828
By:
- Boutin, Lola;
- Scotet, Emmanuel
Publication type:
Article
γ9δ2T cell diversity and the receptor interface with tumor cells.
Published in:
2020
By:
- Vyborova, Anna;
- Beringer, Dennis X.;
- Fasci, Domenico;
- Karaiskaki, Froso;
- van Diest, Eline;
- Kramer, Lovro;
- de Haas, Aram;
- Sanders, Jasper;
- Janssen, Anke;
- Straetemans, Trudy;
- Olive, Daniel;
- Leusen, Jeanette;
- Boutin, Lola;
- Nedellec, Steven;
- Schwartz, Samantha L.;
- Wester, Michael J.;
- Lidke, Keith A.;
- Scotet, Emmanuel;
- Lidke, Diane S.;
- Heck, Albert J. R.
Publication type:
journal article
High-throughput neural stem cell-based drug screening identifies S6K1 inhibition as a selective vulnerability in sonic hedgehog-medulloblastoma.
Published in:
Neuro-Oncology, 2024, v. 26, n. 9, p. 1685, doi. 10.1093/neuonc/noae104
By:
- Zhou, Leilei;
- Bree, Niek van;
- Boutin, Lola;
- Ryu, Jinhye;
- Moussaud, Simon;
- Liu, Mingzhi;
- Otrocka, Magdalena;
- Olsson, Magnus;
- Falk, Anna;
- Wilhelm, Margareta
Publication type:
Article

Found: 4

Camelid‐derived Tcell engagers harnessing human γδ T cells as promising antitumor immunotherapeutic agents.

Towards Deciphering the Hidden Mechanisms That Contribute to the Antigenic Activation Process of Human Vγ9Vδ2 T Cells.

γ9δ2T cell diversity and the receptor interface with tumor cells.

High-throughput neural stem cell-based drug screening identifies S6K1 inhibition as a selective vulnerability in sonic hedgehog-medulloblastoma.